Podcasts about Cancer research

Most advice on public speaking is total garbage that makes you sound robotic. Jay Schwedelson reveals why common tips like memorizing your script or practicing in front of a mirror are actually sabotaging your success. Whether you are on a big stage or in a small conference room, learn why being perfect is boring and how to instantly connect with any audience without telling a single joke.ㅤBest Moments:(01:47) Why memorizing your speech is the fastest way to bore your audience(02:26) The reason practicing in front of a mirror is a total waste of time(02:40) Why you should never practice in silence and how noise helps you prepare(03:45) Stop opening with a joke and try this relatable tactic instead(05:15) The myth of standing still and why you need to physically fill the space(06:45) Why ending with a summary is a mistake and what you should do to drive actionㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

A new social network gained over a million users in a few days, but real people aren't invited to join. Jay Schwedelson breaks down the rise of Molt Book and what these AI agents are actually posting about us behind our backs. Plus, find out why a $10 million Super Bowl ad might be cheaper than you think and the new LinkedIn skill you can officially add to your profile today.ㅤBest Moments:(00:43) A social network exclusively for AI bots grows to 1.5 million agents in just three days(02:05) The minimum ad spend required to advertise on ChatGPT right now(02:40) You can now list Vibe Coding as an official certification on your LinkedIn profile(04:15) Why the headlines about Meghan Markle's products selling out are total marketing nonsense(05:15) Breaking down the math that proves Super Bowl ads are actually a bargain(06:55) The massive reality TV show is returning for its tenth season in OhioㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Bill Thach has had 9 lines of treatment, over 1,000 doses of chemo, and more scans than an airport. He runs ultramarathons for fun. He jokes about being his own Porta Potty. He became a father, then got cancer while his daughter was 5 months old. Today she is 8. He hides the worst of it so she can believe he stands strong, even when he knows that hiding has a cost.We talk about the illusion of strength, what it means to look fine when your body is falling apart, and how a random postcard in an MD Anderson waiting room led him to Man Up to Cancer, where he now leads Diversity and AYA Engagement. Fatherhood. Rage. Sex. Denial. Humor. Survival. All that and why the words good morning can act like a lifeline.RELATED LINKSFight Colorectal CancerCURE TodayINCA AllianceMan Up to CancerWeeViewsYouTubeLinkedInFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most marketers treat automation like a "set it and forget it" task, but that is exactly how you end up with low engagement and ignored emails. Jay Schwedelson connects with Daniel Murray to break down why the best automated sequences do not look automated at all. They also detour into some surprisingly practical relationship advice just in time for Valentine's Day.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(01:52) Why celebrating Valentine's Day a day early might actually be the smarter move(02:37) How to write automated DMs that actually get replies instead of eye rolls(03:30) Using GIFs and multimedia to make welcome emails feel less robotic(04:29) The "Over the Top" strategy of inserting manual emails into automated streams(06:45) Why sending emails at standard times like 9:00 AM is a guaranteed way to be ignored(07:15) The power of sending automations at odd hours like 8:07 PM to boost open ratesㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Tiny tweaks are where the real wins hide, and this one is basically a checklist of easy tests you can run without ripping up your whole marketing stack. Jay Schwedelson pulls rapid-fire insights from billions of emails and thousands of campaigns to show how small layout and UX choices can swing clicks, submissions, and conversions way more than you would expect.ㅤBest Moments:(01:45) Left-justified email copy beats center-justified by 12% on click-through(02:45) Add one reassurance line under a form, and submissions lift by 18%(03:45) About 1 in 5 email clicks hit your logo, so stop wasting that traffic on the homepage(04:42) Every extra required form field drops submissions by around 9%(05:15) Fridays are not dead, webinar attendance is up 75% year over year(06:45) Remove social buttons from your landing page, and conversions rise by over 8%ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

The winners from NASA's Vascular Tissue Challenge are taking their Earth-based research to space.

Our guest today, Dr. Stephen Cabral, is a Board Certified Doctor of Naturopathy and founder of the Integrative Health Practitioner Institute and EquiLife. In his online practice, he uses Personalized Wellness Plans to help people rebalance their mind and body to recover from autoimmune, thyroid, fatigue, hormone, weight gain, digestive, childhood, mood, skin, and dozens of other hard-to-treat health conditions. His mission is to help people understand that there is always a reason why you have not achieved your ideal wellness or weight loss goals and that you can and will get well again.   KEY TOPICS: ·      Understanding Bio-Individuality with Dr. Stephen Cabral's Personomics (0:00) ·      Dr. Cabral's Personal Path to Functional Medicine (3:17) ·      Unpacking the Interconnectedness of Your Biological Ecosystem (7:30) ·      Decoding Your Body's Signals: Energy, Sleep, and Mood (11:25) ·      The Link Between Digestion, Immunity, and Functional Medicine (15:35) ·      How Skin Signals Relate to Aging and Preventable Diseases (19:15) ·      The Future of Health: AI's Impact on Cancer Research (23:20) ·      Empowering Women: Prioritizing Self-Care for a Longer Life (26:14)   RESOURCES + BOOKS MENTIONED: Subscribe: https://www.youtube.com/@herstarringrole Follow + Listen, + Review: APPLE PODCASTS Follow + Listen, + Review: SPOTIFY PODCASTS Join Michele's Newsletter + Get a List of 52-Selfcare Tips   GUEST INFORMATION Website: https://personomics.io/ IG: @stephencabral   If you enjoyed today's show, please share it with a friend. Also, subscribe on Apple Podcasts, or on your favorite podcast player!   *The Good Life with Michele Lamoureux podcast and content provided by Michele Lamoureux is for educational and entertainment purposes only. It does NOT constitute medical, mental health, professional, personal, or any kind of advice or serve as a substitute for such advice. The use of information on this podcast or materials linked from this podcast or website is at the user's own risk. Always consult a qualified healthcare or trusted provider for any decisions regarding your health and wellbeing. This episode may contain affiliate links.

In this episode of Ordinarily Extraordinary: Conversations with Women in STEM, host Kathy Nelson sits down with Dr. Elizabeth Mendes, a newly minted PhD and postdoctoral researcher whose work focuses on rare and aggressive pediatric cancers.Dr. Mendes recently completed her PhD at Duke University, where she spent over five years researching rhabdomyosarcoma, a rare childhood soft-tissue cancer. Her goal: identify new biological targets that could one day lead to better, more effective treatments for children. Kathy and Liz explore not only the science behind pediatric cancer research, but also the deeply human reasons that drive this work.What We Talk About in This EpisodeWhat pediatric sarcomas are—and why they're so challenging to treatLiz breaks down complex cancer biology in an approachable way, explaining how sarcomas differ from more common cancers and why their ability to “change form” makes them particularly dangerous.A non-traditional path into scienceFrom archaeology and zoology to teaching middle school math and science, Liz shares how curiosity—and not a straight line—ultimately led her to molecular biology, cancer research, and a PhD.Choosing pediatric cancer researchLiz explains why she decided to focus on rare childhood cancers that receive less funding but have devastating outcomes—and how personal experiences with cancer shaped that decision.Science close to the patientWe discuss the importance (and rarity) of researchers interacting directly with patients, families, and clinicians—and how those experiences fundamentally change how science is done.Life after the PhD: postdocs, fellowships, and moving to the UKLiz shares what it's like to finish a PhD, move countries, start a new research position, and navigate life and work during a major transition.Being your whole self in STEMFrom makeup and music to mental health and social media, Liz talks about rejecting outdated stereotypes of what scientists “should” look like—and why authenticity matters for the next generation.Representation, mentorship, and science communicationLiz reflects on why visibility matters, especially for women and first-generation students, and how platforms like social media can help make science more accessible and human.A Conversation About More Than ScienceThis episode goes beyond lab work and credentials. It's a candid conversation about grief, resilience, identity, and the responsibility scientists carry—not just to discovery, but to people. Liz's story is a powerful reminder that STEM careers don't require fitting into a mold—and that compassion belongs in science.If you enjoyed this episode:Rate and review the podcast on Apple Podcasts or SpotifyFollow or subscribe so you never miss an episodeShare with a friend, colleague, or student who might need this storyHave thoughts, questions, or guest suggestions?Email us at ordinarilyextraordinarypod@gmail.com or leave a voicemail on our website.Support the show

Social media platforms are suddenly obsessed with long-form writing again, and it feels like 2010 all over again. Jay Schwedelson breaks down why X is paying huge money for articles and why your old blog strategy might actually work on social today. Plus, get the specific keywords that are boosting email open rates right now, ahead of the Super Bowl.ㅤBest Moments:(00:30) X is offering $1 million for the best long-form article on the platform this month(01:50) New data shows Threads is actually beating X in daily mobile usage(03:10) Using specific football terms in subject lines this week can boost opens by 15%(03:50) The single emoji that drives a 20% lift in engagement around the Super Bowl(04:15) You can now use paid boosting to target specific audiences for Facebook Live(05:45) Lululemon is facing backlash over a major product failure with their new yoga pantsㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Shannon Burkett has lived about six lives. Broadway actor. SNL alum. Nurse. Filmmaker. Advocate. Cancer survivor. And the kind of person who makes you question what you've done with your day. She wrote and produced My Vagina—the stop-motion musical kind, not the cry-for-help kind—and built a global movement after her son was poisoned by lead dust in their New York apartment. Out of that came LEAD: How This Story Ends Is Up to Us, a documentary born from rage, science, and maternal defiance. We talked about everything from The Goonies to Patrick Stewart to the quiet rage of parenting in a country that treats public health like a hobby. This episode is about art, anger, resilience, and what happens when an unstoppable theater nerd turned science geek Jersey girl collides with an immovable healthcare system.RELATED LINKSShannon Burkett Official SiteLEAD: How This Story Ends Is Up to UsEnd Lead PoisoningLinkedIn: Shannon BurkettBroadwayWorld ProfileFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Everyone assumes the Super Bowl is strictly for consumer giants with massive ad budgets, but that mindset is a huge missed opportunity for B2B marketers. Jay Schwedelson teams up with Daniel Murray to break down exactly how boring brands can ride the wave of the biggest cultural event of the year without spending a dime on commercials. They share specific keywords that trigger higher open rates during game week and explain why hyper-targeting the cities of the competing teams is the smartest play you can make.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(01:25) Why Jay eats a "disgusting" salmon salad for lunch every day(02:24) Daniel's diet while playing D1 college football at Cincinnati(03:37) Why even the most boring B2B companies need to lean into the Super Bowl(04:45) How to use X (Twitter) during the game to find relevant memes for your brand(06:00) The specific subject line keywords like "MVP" and "QB" that spike engagement(07:15) A clever strategy to target prospects based on which teams make the big gameㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Ever notice how a “No thanks” button can make you feel weirdly judged? That is the whole point of today's quick-hit tactic from Jay Schwedelson, and it can lift conversions fast with a simple two-button rewrite. Then things take a hard left into Jay's personal dream for turning 50: two days on a farm, hanging with chickens, trying to feel like a functional adult.ㅤBest Moments:(00:16) A five-second landing page tweak that can spike conversions without any tech headache(00:57) The magic move: make the Yes button heroic and the No button painfully self-owning(01:45) Big brand examples that use it and why it keeps working on us(03:15) The lift by page type, including a big jump for newsletter signups(03:42) The psychology behind it: framing effect and loss aversion make “No” feel like a loss(06:36) Jay's 50th birthday wish: live on a farm for two days and vibe with the chickensㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Live from IMEX in Las Vegas, the usual “make it more experiential” advice gets flipped on its head. With Jay Schwedelson joined by Ken Holsinger of Freeman and Carina Bauer of IMEX Group, you'll hear why attendees remember the basics (one great connection, one useful idea) way more than the fancy stuff planners pour money into.ㅤDownload and share the IMEX Group and Freeman experiential trends research, then use it to redesign your next event around learning, networking, and business before you spend on “wow” extras.ㅤBest Moments:(01:33) The clearest explanation of what IMEX actually is and who it is really for(05:42) The big “experience” disconnect between what planners build and what attendees want(11:45) The stat that stunned me: planners think 78 percent have a memorable moment, attendees say 40(12:09) If someone meets just one person, retention jumps to 51 percent(12:31) Peak moments drive 85 percent retention, and “gala” never shows up in 2,100 attendee responses(18:21) The best swag ever is either a 20-year-old branded card case or unreleased sneakersㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

AI rumors are getting weirdly specific this week, and the ripple effects are already showing up in places you probably are not watching closely enough. Along the way, Jay Schwedelson connects the dots between LinkedIn suddenly becoming an AI citation machine, ChatGPT testing ads, and a major Constant Contact acquisition that hits close to home. Then it takes a sharp turn into a very firm new rule about movie runtimes and the reality show everyone is apparently addicted to.ㅤBest Moments:(00:30) The rumor that OpenAI is eyeing Pinterest and why tagged images are the real prize(01:19) LinkedIn is getting cited by AI tools 5x more and now outranking Wikipedia and YouTube(02:33) The simple LinkedIn post formula that actually gets pulled into AI citations(03:45) ChatGPT ads are being tested in the US, and what the rollout might look like(05:04) Constant Contact acquired Guru Conference, SubjectLine.com, and Certified Gur,u and what changes (and what does not)(06:42) Marty Supreme review plus the new hard cutoff for movie theater runtimeㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Michael Kramer was 19 when cancer ambushed his life. He went from surfing Florida beaches to chemo, radiation, and a bone marrow transplant that left him alive but carrying a chronic disease. He had necrosis in his knees and elbows, lost his ability to surf for years, and found himself stuck in hospitals instead of the ocean. Yet he adapted. Michael picked up a guitar, built Lego sets, led support groups, and started sharing his story on Instagram and TikTok.We talk about masculinity, identity, and what happens when the thing that defines you gets stripped away. He opens up about dating in Miami, freezing sperm at a children's hospital, awkward Uber-for-sperm moments with his brother, and how meditation became survival. Michael lost his father to cancer when he was a teen, and that grief shaped how he lives and advocates today. He is funny, grounded, and honest about the realities of survivorship in your twenties. This episode shows what resilience looks like when you refuse to walk it off and choose to speak it out loud instead.RELATED LINKSMichael Kramer on InstagramMichael Kramer on TikTokMichael and Mom Inspire on YouTubeAshlee Cramer's BookUniversity of Miami Sylvester Comprehensive Cancer CenterStupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

That “big win” moment is supposed to feel chill, right? Instead, the vibe here is more like: congrats, now the pressure triples. Between Jay Schwedelson admitting he's somehow more anxious after selling subjectline.com and Daniel Murray dropping a ridiculously simple conversion lever most marketers ignore, this one lands as equal parts real talk and immediately usable.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(01:16) Selling a business sounds relaxing until Jay admits it cranked his anxiety up 10x(03:13) The uncomfortable reason Jay sometimes turns down small-budget clients, even when they believe in you(04:48) The easiest conversion lift you can test is not the offer, it's the name of the offer(06:37) The “one modifier word” title test that can change conversions fast(08:12) Why tiny A/B tweaks teach you more than totally different versions(09:15) Jay starts meditating every morning, and Daniel calls him out for the sun-staring habitㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

Will Uganda's pop-star politician prevail? Is dodgy data undermining medical research? And what does a new app reveal about Chinese society? Olly Mann and The Week delve behind the headlines and debate what really matters from the past seven days. With Jamie Timson, Felicity Capon and Harriet MarsdenImage credit: Michel Lunanga/Getty Images

Ever stare at an AI tool and think, cool, but how do I make it write like a real marketer? Jay Schwedelson brings on Michael Stelzner to break down why Claude is the go-to for persuasive copy and how to set it up so it actually learns your style instead of forgetting everything five minutes later. If you have been fighting custom GPT amnesia, this one will feel like a reset.ㅤGet $100 off the already discounted AI Business World ticket here:https://www.socialmediaexaminer.com/dothisAlso check out Michael's AI Explored podcast for weekly, practical AI tactics.ㅤBest Moments:(02:08) Why Claude is the best writer for persuasive marketing copy(04:05) The simplest explanation of Claude Projects and why they beat custom GPTs(05:30) The “artifact” trick that turns messy output into clean, usable docs(06:45) Uploading 1,000 testimonials and letting Claude pull the perfect snippets automatically(11:38) The ninja prompt move: generate 8 options, then force the AI to pick the best(16:57) The quick pitch for AI Business World and the $100 listener discountㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

New research is transforming the outlook for cervical and uterine cancers -- two of the most serious gynecologic malignancies worldwide – and we'll be hearing from one of the people shaping that progress, Dr. Mary McCormack, on this episode of Raise the Line. From her perch as the senior clinical oncologist for gynecological cancer at University College London Hospitals, Dr. McCormack has been a driving force in clinical research in the field, most notably as leader of the influential INTERLACE study, which changed global practice in the treatment of locally advanced cervical cancer, a key reason she was named to Time Magazine's 2025 list of the 100 most influential people in health. “In general, the protocol has been well received and it was adopted into the National Comprehensive Cancer Network guidelines which is a really big deal because lots of centers, particularly in South and Central America and Southeast Asia, follow the NCCN's lead.”In this conversation with host Michael Carrese, you'll learn about how Dr. McCormack overcame recruitment and funding challenges, the need for greater access to and affordability of treatments, and what lies ahead for women's cancer treatment worldwide. Mentioned in this episode:INTERLACE Cervical Cancer Trial If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Daniel Garza had momentum. Acting roles, directing gigs, national tours lined up. Then anal cancer stopped everything. Radiation wrecked his body, stripped him of control, and left him in diapers, staring down despair. His partner, Christian Ramirez, carried him through the darkest nights, changed his wounds, fought hospitals, and paid the price with his own health. Christian still lives with permanent damage from caregiving, but he stayed anyway.Together they talk with me about masculinity, sex, shame, friendship, and survival. They describe the friendships that vanished, the laughter that kept them alive, and the brutal reality of caregiving no one prepares you for. We get into survivor guilt, PTSD, and why even rocks need rocks. Daniel is now an actor, director, and comedian living with HIV. Christian continues to tell the unfiltered truth about what it takes to be a caregiver and stay whole. This episode gives voice to both sides of the cancer experience, the survivor and the one who stands guard. RELATED LINKSDaniel Garza IMDbDaniel Garza on InstagramDaniel Garza on FacebookChristian Ramirez on LinkedInLilmesican Productions Inc (Daniel & Christian)Stupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How has immunotherapy evolved in the last decade? In this episode of The Chain, Laszlo Radvanyi, professor of immunology at the University of Toronto, discusses his years-long research on cancer immunotherapy, including his time at MD Anderson, with host Rakesh Dixit. He shares his thoughts on agonist antibodies, the true breakthroughs that are moving the needle for patients, reducing the CD-28 pathway so that it doesn't produce cytokine toxins, and what is the next frontier in immunotherapy. Links from this episode:  EpiVax University of Toronto, Department of Immunology University of Toronto  

In this episode of Parts and Labor, Angela Chaudhari, MD, hosts a panel of experts from Northwestern Medicine's Division of Gynecologic Oncology to discuss the groundbreaking research and clinical trials shaping the future of gynecologic cancer care. The panel explores innovations in immunotherapy, investigator-initiated trials, survivorship and symptom science, while highlighting efforts to expand access and diversity in clinical research across Chicago and the surrounding suburbs.This episode's panel of guests includes:• Emma L. Barber, MD, John and Ruth Brewer Professor of Gynecology and Cancer Research, Division Chief of Gynecologic Oncology and Director of Robotic Surgery• Daniela E. Matei, MD, Diana, Princess of Wales Professor of Cancer Research and Chief of Reproductive Science in the Departments of Obstetrics and Gynecology and Hematology and Oncology• Dario R. Roque, MD, Associate Professor of Gynecologic Oncology and Fellowship Program Director• Emily M. Hinchcliff, MD, Assistant Professor of Gynecologic Oncology and Program Director of the OB-GYN Residency Program

In this talk, Rileen, a Senior Computational Biologist and Cancer Data Scientist, shares his professional journey from physics and computer science to cutting-edge cancer genomics and applied machine learning. From his early work in alternative splicing models to deep learning in medical imaging, Rileen explains how biology, data science, and AI intersect to transform cancer research.TIMECODES:00:00 Rileen's Career Journey and Education06:14 Understanding Alternative Splicing in Computational Biology10:56 Modeling Alternative Splicing with Machine Learning14:52 Model Error Analysis and Transition to Cancer Research18:37 What Is Cancer? Mutational Theory Explained21:45 Cancer Treatments and Causes24:57 Cancer Genomics and Tumor Models28:59 Comparing Cell Lines and Tumor Samples (Multi-omics Analysis)32:32 Machine Learning Applications in Cancer Research35:38 Deep Learning for Medical Imaging and Pathology39:17 Data Privacy and Applied ML Course Projects42:50 Learning Outcomes and Future Plans46:36 Industry Experience in Pharmaceutical Research50:14 Day in the Life of a Computational Biologist55:02 Advice for Current ML Students58:40 Project Management and Challenges in Genomics1:02:23 Public Data Sets and Cancer Research in GermanyConnect with Rileen:- Twitter - https://x.com/RileenSinha- Linkedin - https://www.linkedin.com/in/rileen-sinha-a644692/- Github - https://github.com/OptimistixConnect with DataTalks.Club:- Join the community - https://datatalks.club/slack.html- Subscribe to our Google calendar to have all our events in your calendar - https://calendar.google.com/calendar/r?cid=ZjhxaWRqbnEwamhzY3A4ODA5azFlZ2hzNjBAZ3JvdXAuY2FsZW5kYXIuZ29vZ2xlLmNvbQ- Check other upcoming events - https://lu.ma/dtc-events- GitHub: https://github.com/DataTalksClub- LinkedIn - https://www.linkedin.com/company/datatalks-club/ - Twitter - https://twitter.com/DataTalksClub - Website - https://datatalks.club/

This episode is another very personal one. My son eight year old son William was diagnosed with medulloblastoma nearly a year ago. He's since on embarked on an incredible journey of brain surgery, radiation, and chemotherapy – and recently rang the bell completing his treatment right before Thanksgiving.His response to this adversity has been nothing short of amazing and awe-inspiring. His smile and laughter has never ceased, his poise and strength are well-beyond his years, and I've chronicled his story on LinkedIn – where you'll see his incredible strength and optimism on display. Along the way, I've met some incredible people and world changers. One of those world changers is Dr. Jim Olson from Seattle Children's. James M. Olson, MD, PhD, is program director for the Invent at Seattle Children's Postdoctoral Scholars Program, a principal investigator in the Ben Towne Center for Childhood Cancer and Blood Disorders Research, and a professor at the University of Washington School of Medicine. He co-founded three biotechnology companies and has mentored more than 30 graduate students and postdoctoral research fellows. He chaired a national phase III clinical trial for high-risk medulloblastoma patients that led to a 20% improvement in five-year survival for Group 3 patients. Dr. Olson is the principal investigator on multiple projects that focus on developing effective new therapies for pediatric brain tumors; methods that allow surgeons to better visualize the border of brain cancer and normal brain, and the discovery of immunotherapeutics for several cancers. Dr. Olson's game changing research in immunotherapy could potentially revolutionize the standard of care as we know it – and has the potential to replace radiation and chemotherapy. In lab trials, this treatment completely eliminated cancer in 90% of brain tumors that are otherwise universally fatal in children. Mice that received the treatment were alive and disease-free, while the untreated mice died within 18 days.In this podcast, we discuss his research, next steps for funding and clinical trials – and what this could mean for families moving forward. Please enjoy this conversation and donate to Dr. Olson's groundbreaking immunotherapy trial here.

Trevor Maxwell lived the archetype of masculinity in rural Maine. Big, strong, splitting wood, raising kids, and carrying the load. Then cancer ripped that script apart. In 2018 he was bedridden, emasculated, ashamed, and convinced his family would be better off without him. His wife refused to let him disappear. That moment forced Trevor to face his depression, get help, and rebuild himself. Out of that came Man Up To Cancer, now the largest community for men with cancer, a place where men stop pretending they are bulletproof and start being honest with each other.Eric Charsky joins the conversation. A veteran with five cancers, forty-nine surgeries, and the scars to prove it, Eric lays out what happens when the military's invincible mindset collides with mortality. Together, we talk masculinity, vulnerability, sex, shame, and survival. This episode is blunt, raw, and overdue.RELATED LINKSMan Up To CancerTrevor Maxwell on LinkedInDempsey CenterEric Charsky on LinkedInStupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein to discuss the role of the media in lung cancer awareness and perception. Traditional media, including television and radio, do much to shape the public perception of lung cancer and healthcare in general. Meg Tirrell and Neal Augenstein share their experiences reporting in the health sector, establishing trust with their audiences in the face of uncertainty, and distilling complex medical information to the general public.

Stephan Stern, PhD, DABT, Director of Research and Development, Nanotechnology Characterization Lab (NCL), Frederick National Laboratory for Cancer Research, Maryland, USA; and Ruben Boado, PhD, Professor of Medicine, University of California at Los Angeles, California, USA, discuss the use of nanotechnology in the treatment of lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session2-nanotechnology-and-lysosomal-disorders/Learning ObjectivesDescribe recent advances in the use of nanotechnology to treat lysosomal disordersDescribe the role of nanotechnology in addressing unmet needs in lysosomal disordersFacultyStephan Stern, PhD, DABTDirector of Research and Development, Nanotechnology Characterization Lab (NCL), Frederick National Laboratory for Cancer ResearchRuben Boado, PhDProfessor of Medicine, University of California at Los AngelesDisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Stephan Stern, PhD, DABTDr. Stern has no relevant financial relationships to disclose. Ruben Boado, PhDDr. Boado has no relevant financial relationships to disclose.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

Mia Horowitz, PhD, Tel Aviv University; Aitor Aguirre, PhD, Michigan State University, Michigan, USA; and Ying Sun, PhD, University of Cincinnati, discuss the use of organoid models in lysosomal disorder research and drug development.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session3-organoids-and-lab-grown-models-in-lysosomal-disorders/Learning ObjectivesDescribe the use of heart organoid models to better understand the pathophysiology of lysosomal disorders and its clinical relevanceDescribe the use and application of brain organoid models in neuropathic Gaucher disease research and treatmentFacultyMia Horowitz, PhD, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University.Aitor Aguirre, PhD, Associate Professor of Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Chief, Division of Developmental and Stem Cell Biology (IQ), Director, MSU Stem Cell Core, Michigan State University.Ying Sun, PhD, Professor, Cincinnati Children's Hospital Medical Center, University of Cincinnati.DisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Mia Horowitz, PhDDr. Horowitz has no relevant financial relationships to disclose.Aitor Aguirre, PhDDr. Aguirre has no relevant financial relationships to disclose.Ying Sun, PhDDr. Sun receives research support from Enkefalos Biosciences and Yuhan Corporation.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

The most anticipated annual tradition on Out of Patients returns with the 2025 Holiday Podcast Spectacular starring Matthew's twins Koby and Hannah. Now 15 and a half and deep into sophomore year, the twins deliver another unfiltered year end recap that longtime listeners wait for every December. What began as a novelty in 2018 has become a time capsule of adolescence, parenting, and how fast childhood burns off.This year's recap covers real moments from 2025 A subway ride home with a bloodied face after running full speed into that tree that grows in Brooklyn. Broadway obsessions fueled by James Madison High School's Roundabout Youth Ensemble access, including Chess, & Juliet, Good Night and Good Luck, and Pirates of Penzance holding court on Broadway. A Disneylanmd trip where the Millennium Falcon triggered a full system reboot. A New York Auto Show pilgrimage capped by a Bugatti sighting. All the things.The twins talk school pressure, AP classes, learner permit anxiety, pop culture fixation, musical theater devotion, and the strange clarity that comes with turning 15. The humor stays sharp, the details stay specific, and the passage of time stays undefeated. This episode lands where the show works best: family, honesty, and letting young people speak for themselves.FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, interviews Dr. Brent Sear, director of the Clinical Pharmacology Shared Resource at KU Cancer Center. Brent shares his unique career journey into clinical pharmacology, the role of clinical pharmacology in advancing cancer therapies, and the critical work his team does in guiding clinical trials and personalizing cancer treatment. They also discuss emerging technologies and their potential impact on the future of cancer research. Tune in to learn more about the intricate processes that ensure safe and effective cancer therapies. 00:00 Introduction to the Podcast and Guest 01:06 Brent Sear's Journey into Cancer Research 03:21 Understanding Clinical Pharmacology 04:54 The Role of Clinical Pharmacology Shared Resource 06:40 Importance of Precise Measurement in Cancer Treatment 08:40 Collaborative Projects and Scientific Insights 09:55 Advice for Aspiring Researchers 11:52 Future of Clinical Pharmacology in Cancer Research 13:33 Conclusion and Farewell Links from this Episode: ·       Learn more about the Clinical Pharmacology Shared Resource at KU Cancer Center ·       Learn about Brent Sear, director of the Clinical Pharmacology Shared Resource ·       Learn about Shared Resources and Core Facilities at KU Cancer Center To ensure you get our latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center.

Jason Gilley walked into adulthood with a fastball, a college roster spot, and a head of curls that deserved its own agent. Cancer crashed that party and took him on a tour of chemo chairs, pediatric wards, metal taste, numb legs, PTSD, and the kind of late night panic that rewires a kid before he even knows who he is.I sat with him in the studio and heard a story I know in my bones. He grew up fast. He learned how to stare down mortality at nineteen. He found anchors in baseball, therapy, and the strange friendships cancer hands you when it tears your plans apart. He owns the fear and the humor without slogans or shortcuts. Listeners will meet a young man who refuses to let cancer shrink his world. He fights for the life he wants. He names the truth without apology. He reminds us that survivorship stays messy and sacred at the same time. This conversation will stay with you.RELATED LINKS• Jason Gilley on IG• Athletek Baseball Podcast• EMDR information• Children's Healthcare of AtlantaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

EPISODE SUMMARY: Lesley Visser is the most highly acclaimed female sportscaster of all time. She shares her journey to becoming the first woman to achieve numerous recognitions, the people who helped get her there, and many great stories from along the way.Visser was honored as a Giants of Broadcasting by the Library of American Broadcasting Foundation at the 2025 Giants of Broadcasting & Electronic Arts luncheon and awards ceremony.On this episode of Chachi Loves Everybody, Chachi talks to Lesley Visser about:Growing up with a love of sports and getting a Carnegie Foundation scholarship to go into the male-dominated field of sports writingThe terrifying but exciting honor of being the first woman to cover the NFL Beat at The Boston GlobeTransitioning from writing to broadcasting on TV at CBS SportsGetting to present the Lombardi TrophyTraveling the world to report on major news such as the fall of the Berlin WallWorking with other legendary sports figures like Greg Gumbel and Terry Bradshaw, and riding on John Madden's busThe greatest events she's covered from Super Bowls to Final Fours to The Olympics and moreWhat it means to be a trailblazing woman, how sports reporting is evolving, and the progress that must still be madeThe role of technology in sports journalism, and her advice to future journalistsAnd More!ABOUT THIS EPISODE'S GUEST: Lesley Visser is the most highly acclaimed female sportscaster of all time. Across numerous accolades, she has been the “First” – the First woman enshrined in the Pro Football Hall of Fame; the First woman to win the Lifetime Achievement Sports Emmy and the First woman to win the Broadcasters Foundation of America Lifetime Achievement Award; the First woman on the Network broadcasts of the Final Four, the NBA Finals, the Super Bowl and the World Series. She is the First and only woman to have presented the Championship Lombardi Trophy at the Super Bowl. She was the First woman to cover the NFL as a beat, the First woman on Monday Night Football and the First female NFL analyst in both Radio and TV. She was the First female sportscaster to carry the Olympic Torch and the only winner of the Billie Jean King “Outstanding Journalist Award.”Visser is the only sportscaster – male or female – to have worked on the network broadcasts of the Final Four, the Super Bowl, the NBA Finals, the Olympics, the World Series, the Triple Crown, the World Figure Skating Championship and the US Open Tennis.Visser was voted the No. 1 Female Sportscaster of All-Time by the National Sportscasters of America. Her career began at the Boston Globe in 1974 after she won a Carnegie Foundation grant, given to only 20 women in the country who wanted to go into jobs that were 95% male. The Boston Globe made her the First woman to cover the NFL as a beat, at a time when the credentials said, "No Women or Children in the Press Box." She was elected to the National Sports Media Hall of Fame for her writing at the Boston Globe, magazines and CBS.com, and she was voted to the Sportscasters Hall of Fame for her work at CBS, ABC, ESPN and HBO. Visser has been named a Muhammad Ali “Daughter of Greatness” and won the Newseum Award for Lifetime Achievement – First given to Walter Cronkite. She reported from the fall of the Berlin Wall in 1989, focusing on how sports would change in East Germany after reunification, and had the privilege, in 2013, of throwing out the First pitch for her beloved Red Sox. In October 2024, she was honored with the Vin Scully Award for Excellence in Sports Broadcasting by Fordham University's public media service, WFUV.A graduate of Boston College, which awarded her an Honorary Doctorate in 2007, she served on the Board of the V Foundation for Cancer Research for more than 20 years, while also serving on the Board of NYU's “Sports and Society.” Visser has mentored young women for decades, while speaking at colleges and businesses around the world – from Doha, Qatar, to Charleston, South Carolina, where she delivered an address at the Renaissance Weekend, founded by President Clinton. Her book, Sometimes You Have to Cross When It Says Don't Walk, is a memoir of breaking barriers. It has been optioned for both a movie and a TV series.The Hall of Fame sportscaster has spent more than 30 years at CBS and more than 45 in the business. She is a contributor to the only all-female network sports show, We Need To Talk, on CBS, and had a podcast, In Conversation with Lesley Visser, on SiriusXM. Visser has been voted one of the “Women we Love” by Esquire magazine and one of the “Five Ideal Dinner Guests” by GQ.She and her husband, Bob Kanuth, a former captain of Harvard basketball, live in Bay Harbor Islands, Florida.ABOUT THE PODCAST: Chachi Loves Everybody is brought to you by Benztown and hosted by the President of Benztown, Dave “Chachi” Denes. Get a behind-the-scenes look at the myths and legends of the radio industry.ABOUT BENZTOWN: Benztown is a leading international audio imaging, production library, voiceover, programming, podcasting, and jingle production company with over 3,000 affiliations on six different continents. Benztown provides audio brands and radio stations of all formats with end-to-end imaging and production, making high-quality sound and world- class audio branding a reality for radio stations of all market sizes and budgets. Benztown was named to the prestigious Inc. 5000 by Inc. magazine for five consecutive years as one of America's Fastest-Growing Privately Held Companies. With studios in Los Angeles and Stuttgart, Benztown offers the highest quality audio imaging work parts for 23 libraries across 14 music and spoken word formats including AC, Hot AC, CHR, Country, Hip Hop and R&B, Rhythmic, Classic Hits, Rock, News/Talk, Sports, and JACK. Benztown's Audio Architecture is one of the only commercial libraries that is built exclusively for radio spots to provide the right music for radio commercials. Benztown provides custom VO and imaging across all formats, including commercial VO and copywriting in partnership with Yamanair Creative. Benztown Radio Networks produces, markets, and distributes high-quality programming and services to radio stations around the world, including: The Rick Dees Weekly Top 40 Countdown, The Todd-N-Tyler Radio Empire, Hot Mix, Sunday Night Slow Jams with R Dub!, Flashback, Top 10 Now & Then, Hey, Morton, StudioTexter, The Rooster Show Prep, and AmeriCountry. Benztown + McVay Media Podcast Networks produces and markets premium podcasts including: IEX: Boxes and Lines and Molecular Moments.Web: benztown.comFacebook: facebook.com/benztownradioTwitter: @benztownradioLinkedIn: linkedin.com/company/benztownInstagram: instagram.com/benztownradio Enjoyed this episode of Chachi Loves Everybody? Let us know by leaving a review!

Dr. Marissa Russo trained to become a cancer biologist. She spent four years studying one of the deadliest brain tumors in adults and built her entire research career around a simple, urgent goal: open her own lab and improve the odds for patients with almost no shot at survival. In 2024 she applied for an F31 diversity grant through the NIH. The reviewers liked her work. Her resubmission was strong. Then the grant system started glitching. Dates vanished. Study sections disappeared. Emails went silent. When she finally reached a program officer, the message was clear: scrub the DEI language, withdraw, and resubmit. She rewrote the application in ten days. It failed. She had to start over. Again. This time with her identity erased.Marissa left the lab. She found new purpose as a science communicator, working at STAT News through the AAAS Mass Media Fellowship. Her story captures what happens when talent collides with institutional sabotage. Not every scientist gets to choose a Plan B. She made hers count.RELATED LINKSMarissa Russo at STAT NewsNIH F31 grant story in STATAAAS Mass Media FellowshipContact Marissa RussoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Scott Capozza and I could have been cloned in a bad lab experiment. Both diagnosed with cancer in our early twenties. Both raised on dial-up and mixtapes. Both now boy-girl twin dads with speech-therapist wives and a lifelong grudge against insurance companies. Scott is the first and only full-time oncology physical therapist at Yale New Haven Health, which means if he catches a cold, cancer rehab in Connecticut flatlines. He's part of a small, stubborn tribe of providers who believe movement belongs in cancer care, not just after it. We talked about sperm banking in the nineties, marathon training during chemo, and what it means to be told you're “otherwise healthy” when your lungs, ears, and fertility disagree. Scott's proof that survivorship is not a finish line. It's an endurance event with no medals, just perspective.RELATED LINKSScott Capozza on LinkedIn: https://www.linkedin.com/in/scott-capozza-a68873257Yale New Haven Health: https://www.ynhh.orgExercising Through Cancer: https://www.exercisingthroughcancer.com/team/scott-capozza-pt-msptProfiles in Survivorship – Yale Medicine: https://medicine.yale.edu/news-article/profiles-in-survivorship-scott-capozzaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Angus Read graduated from university in July and, like any adventurous 22-year-old, wanted to go travelling. His plans grew, as did his desire to do something to not only better himself, but also raise money for charity, so he planned to do it all - a solo trip where he'd make his way across Europe, running a marathon in as many countries as he could, fund raising for Cancer Research. He's just finished this four month long trip and joined us to discuss the planning of such a trip, why running solo across Europe was the best experience he could have hoped for and how a rogue pizza in London nearly scuppered the whole experience.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Game Over: c*ncer really lives up to its name in this one. In this special episode, we celebrate 10 years of impact with the very first researcher Cannonball Kids' cancer Foundation (CKc) ever funded, Dr. Ted Johnson.Dr. Johnson is a professor of pediatric oncology and co-director of the Pediatric Immunotherapy Program at Augusta University, a destination program for children with brain cancer who have run out of standard options. Val Solomon and Dana Nichols sit down with him to talk about how one early CKc grant helped launch a decade of progress in pediatric brain cancer immunotherapy, from saving and studying monthly blood samples to building a powerful biological sample bank that is now changing what is possible for kids.You will hear how a “leap of faith” investment became the spark behind clinical trials that have now provided experimental immunotherapy to more than 270 children and young adults from over 30 states. Dr. Johnson explains how indoximod-based immunotherapy works, why activating a child's immune system is so rare and so important, and how small donations, bake sales, and grassroots philanthropy truly keep this work alive.The conversation also pulls back the curtain on CKc's Scientific Advisory Board, why it was built to push research out of the lab and into the clinic, and how that original vision has grown into a Zoom screen full of experts carefully reviewing targeted grants that directly impact kids and families. Dr. Johnson shares what he is seeing on the NIH Review Board, why pediatric grants are still outnumbered by adult oncology proposals, and what this means for the future of funding and innovation in childhood cancer.If you have ever wondered whether your $50 or $100 really matters, this episode is for you. You will hear exactly how early seed funding, focused clinical trial grants, and community support create a snowball effect that leads to new therapies, better outcomes, and real hope for children with brain cancer.Learn more about the grants we fund, our Scientific Advisory Board, and how to make a gift at: cannonballkidscancer.orgIf this conversation encourages you, please like this video, subscribe to the Game Over: c*ncer Podcast, and share it with someone who cares about changing the future for kids with cancer.Together, we can transform fear and fuel the next decade of breakthroughs.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Research has been at the heart of NETRF's mission for 20 years—and patients are the reason that work matters. Every study we fund is designed to move the field forward and improve how people with neuroendocrine cancer live, feel, and are treated. In this special episode of NETWise, we're bringing the 2025 NETRF Neuroendocrine Cancer […] The post NETWise Episode 50: The Year in Review 2025: Neuroendocrine Cancer Research and Clinical Progress appeared first on NETRF.

Ann Meyn started her advocacy in the 1990s, launching support groups and sharing the message of early detection. Even while facing aggressive treatments, she continued teaching, volunteering, and helping others understand cancer. With a scientific mindset, she shaped patient support and influenced research, guiding the next generation of advocates. Today, she joins Dorothy to reflect on their friendship and impact on The Rose’s community. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. What was the Rosebuds group and why was it created?2. How did the Rose operate to serve both insured and uninsured women?3. Why were support groups for breast cancer patients so important?4. How did breast cancer treatment approaches change over time?5. What was Ann Meyn’s personal experience with breast cancer diagnosis and treatment?6. How have support group needs varied among different groups of women?7. How has patient advocacy in breast cancer research evolved, and why is it important?8. How has breast cancer detection and awareness changed, especially for younger women?9. What advances have been made in breast cancer research and treatment in recent years?10. What advice does Ann Meyn have for women regarding breast health?11. What is the psychological impact of support, both from groups and families, in the journey of breast cancer?12. What are the challenges for caregivers vs. being the patient?13. How can survivors and educators help reduce the stigma or fear around cancer for children and families?14. What changes occurred in support and treatment during and after the COVID-19 pandemic? Timestamped Overview 00:00 Passion Behind The Rose Concept 05:22 Reflecting on Terminal Cancer Cases 08:53 Breast Cancer Misdiagnosis Experience 11:43 Teaching Through Chemo Treatments 14:52 Patient Advocacy and Cancer Research 19:33 Advances in Cancer Diagnostics 20:41 Resilience, Discovery, and Complexity 24:31 Advances in Radiation Treatment 27:58 Complex Surgeries and Recovery 32:57 Taking Fear Away Through ConnectionSee omnystudio.com/listener for privacy information.

Dr. MaryAnn Wilbur trained her whole life to care for patients, then left medicine behind when it became a machine that punished empathy and rewarded throughput. She didn't burn out. She got out. A gynecologic oncologist, public health researcher, and no-bullshit single mom, MaryAnn walked straight off the cliff her career breadcrumbed her to—and lived to write the book.In this episode, we talk about what happens when doctors are forced to choose between their ethics and their employment, why medicine now operates like a low-resource war zone, and how the system breaks the very people it claims to elevate. We cover moral injury, medical gaslighting, and why she refused to lie on surgical charts just to boost hospital revenue.Her escape plan? Tell the truth, organize the exodus, and build something that actually works. If you've ever wondered why your doctor disappeared, this is your answer. If you're a clinician hiding your own suffering, this is your permission slip.RELATED LINKSMaryAnn Wilbur on LinkedInMedicine ForwardClinician Burnout FoundationThe Doctor Is No Longer In (Book)Suck It Up, Buttercup (Documentary)FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

2025: The Year America Got Thinner — But Not Healthier | Media Power Grabs & Cancer Truths 2025 is being called “the year America shed” — with more people losing weight than ever thanks to fad diets, Ozempic, Wegovy, Zepbound, and every quick-fix trend imaginable. But here's the shocking truth: Americans may be getting thinner, but not healthier. Why? Today we break down the real reasons behind the wellness illusion. Then, a massive story almost no one is paying attention to: the brewing Warner Bros. takeover battle. Donald Trump, backed by Saudi money and his son-in-law Jared Kushner, is pushing for a hostile takeover to compete with (and control) Netflix. What's the motive? What does it mean for media, entertainment, and democracy? We dig into the power dynamics behind the scenes. Plus — new, surprising research on cancer detection asks a provocative question: Should all cancers be found? The answer isn't what you think. The Karel Cast is funded by your support at patreon.com/reallykarel. Watch, like, comment, and subscribe at youtube.com/reallykarel. Listen on all major platforms: Apple Music, Spotify, iHeartMedia, Spreaker, and more. Catch the show Monday through Thursday at 10:30 AM PST, with daily clips on TikTok and Instagram. Karel is a history-making broadcaster based in Las Vegas with his service girl, Ember — bringing bold commentary, big stories, and unfiltered truth. #TheKarelCast, #2025Trends, #OzempicCulture, #WeightLossTruth, #Wegovy, #Zepbound, #AmericanHealthCrisis, #MediaTakeover, #WarnerBrosDeal, #TrumpNews, #JaredKushner, #SaudiMoney, #NetflixWar, #CancerResearch, #HealthMyths, #PoliticalCommentary, #NewsAnalysis2025, #LasVegasCreator, #LGBTQCommentator, #PodcastLife https://youtube.com/live/NPftX-i5_EU

Dr. Trudy G. Oliver is a Professor in the Department of Pharmacology & Cancer Biology as well as a Duke Science and Technology Scholar at Duke University. Trudy's research focuses on small cell lung cancer, a disease known for its remarkable ability to "shape-shift" or undergo cellular plasticity. This adaptability allows cancer cells to change types and develop different therapeutic vulnerabilities (or invulnerabilities), making treatment especially challenging and preventing the development of a one-size-fits-all approach. When she's not in the lab, Trudy unwinds with walks, jogs, music, and true-crime podcasts. She also enjoys spending quality time with friends, family, and her two energetic orange kittens named Basal and Tuft after her favorite lung cell types. She received her Bachelor's degree in chemistry from Oklahoma Baptist University, and her PhD in cancer biology from Duke University. Afterwards, she conducted postdoctoral research at the University of North Carolina, Chapel Hill, and subsequently at MIT. Trudy served on the faculty at the University of Utah for more than a decade before joining the faculty at Duke University where she is today. She has received numerous awards and honors for her work, including the Heine H. Hansen Lectureship Award for Small Cell Lung Cancer from the IASLC World Lung Conference, the William C. Rippe Award for Distinguished Research in Lung Cancer from the Lung Cancer Research Foundation, the Lung Cancer Discovery Award from the American Lung Association, the American Cancer Society Research Scholar Award, the Damon Runyon-Rachleff Innovation Award, and the Jimmy V Scholar Award from the V Foundation for Cancer Research. In this interview, Trudy shares more about her life and science.

Episode 5 of Standard Deviation with Oliver Bogler on the Out of Patients podcast feed pulls you straight into the story of Dr Ethan Moitra, a psychologist who fights for LGBTQ mental health while the system throws every obstacle it can find at him.Ethan built a study that tracked how COVID 19 tore through an already vulnerable community. He secured an NIH grant. He built a team. He reached 180 participants. Then he opened an email on a Saturday and learned that Washington had erased his work with one sentence about taxpayer priorities. The funding vanished. The timeline collapsed. His team scattered. Participants who trusted him sat in limbo.A federal court eventually forced the government to reinstate the grant, but the damage stayed baked into the process. Ethan had to push through months of paperwork while his university kept the original deadline as if the shutdown had not happened. The system handed him a win that felt like a warning.I brought Ethan on because his story shows how politics reaches into science and punishes the people who serve communities already carrying too much trauma. His honesty lands hard because he names the fear now spreading across academia and how young scientists question whether they can afford to care about the wrong population.You will hear what this ordeal did to him, what it cost his team, and why he refuses to walk away.RELATED LINKSFaculty PageNIH Grant DetailsScientific PresentationBoston Globe CoverageFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Chelsea J. Smith walks into a studio and suddenly I feel like a smurf. She's six-foot-three of sharp humor, dancer's poise, and radioactive charm. A working actor and thyroid cancer survivor, Chelsea is the kind of guest who laughs while dropping truth bombs about what it means to be told you're “lucky” to have the “good cancer.” We talk about turning trauma into art, how Shakespeare saved her sanity during the pandemic, and why bartending might be the best acting class money can't buy. She drops the polite bullshit, dismantles survivor guilt with punchline precision, and reminds every listener that grace and rage can live in the same body. If you've ever been told to “walk it off” while your body betrayed you, this one hits close.RELATED LINKS• Chelsea J. Smith Website• Chelsea on Instagram• Chelsea on Backstage• Chelsea on YouTube• Cancer Hope Network• Artichokes and Grace – Book by Chelsea's motherFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

* Latest Science News: This week Fred Williams and Doug McBurney review headlines from the world of immunotherapy and cancer research, the Epoch Times, Evolutionary Cosmology & Hydroplate Theory. * God's Shooting Video: Hear a theory (that's at least as plausible as others) for how God can have eyes everywhere as Proverbs 15:3 says! * Gunning for Cancer: We'll cover the latest advances in cancer research, which sees doctors injecting one tumor with CD40 agonist antibody 2141-V11, eliminating it, and many more, using compounds created by the immune system God gave ya! * Epoch Rewrite: Hear the story of Antarctic Ice that has defied erosion for 6 million years, and once again rewritten a host of old earth/climate fairy tales. * The Big Roll: How did frozen & fossilized tropical plants and animals end up in the arctic? And what are Mammoths discovered, frozen and with tropical plants, undigested in their stomachs? Walt Brown's Hydroplate Theory offers a plausible explanation!

Patrick Vallance, the minister for science, research and innovation, recently unveiled a plan to cut animal testing through greater use of AI and other technologies, with the eventual aim of phasing it out altogether. To understand how this will affect research and what could be used in place of animal models, Madeleine Finlay hears from science editor Ian Sample, Prof Hazel Screen of Queen Mary University London and Prof Kevin Harrington from the Institute of Cancer Research. Help support our independent journalism at theguardian.com/sciencepod

In this episode, Dr. Jockers and Dr. Chris D'Adamo break down how your immune system learns, adapts, and strengthens over time—and why beta-glucan is one of the most researched natural compounds for resilience. You'll hear how immune modulation, not just stimulation, can keep you healthy through stress, seasonal shifts, and everyday exposures.   You'll learn how gut health, stress hormones, and immune function are deeply connected, and why improving your stress tolerance starts with lowering inflammation and supporting your microbiome. Dr. D'Adamo explains the science behind cortisol, trained immunity, and the role beta-glucan plays in balancing your system long before symptoms appear.   You'll also discover why immune aging may be one of the biggest drivers of biological aging—and how supporting your innate defenses can influence longevity, energy, and mood. Throughout the conversation, you'll pick up practical strategies you can start using today to strengthen immunity in a real, sustainable way.   In This Episode:  00:00 Introduction to Beta-Glucan and Cancer Research 00:37 Training Your Immune System 01:23 Beta-Glucan: Sources and Benefits 05:48 Interview with Dr. Chris D'Adamo: Immune System Focus 08:07 Beta-Glucan and Immune Modulation 09:44 Cold and Flu Season: Immune System Tips 11:24 Beta-Glucan and Biological Aging 17:45 Beta-Glucan Dosage and Usage 20:23 Personal Immune System Strategies 22:55 Trained Immunity and Beta-Glucan 25:14 Beta-Glucan and Cortisol Reduction 30:05 The Role of Beta-Glucan in Detoxification 33:07 Supplements and Modern Toxicity 34:45 Beta-Glucan for Kids 36:26 Exciting Research on Immune Health 39:17 Daily Habits for a Strong Immune System 42:12 The Benefits of Sauna and Cold Exposure 47:10 Choosing the Right Beta-Glucan Supplement 48:28 Conclusion and Final Thoughts Hydration is one of the fastest ways to boost your energy, sharpen your focus, curb cravings, and even improve the look and feel of your skin — but water alone isn't enough. Your cells need electrolytes to actually absorb and use that hydration. Paleovalley Essential Electrolytes delivers premium, full-spectrum minerals with zero sugar, no artificial ingredients, and unprocessed sea salt, helping you feel more energized, clear-headed, and vibrant — and look more radiant from the inside out. Just one scoop a day can make a noticeable difference. Try Paleovalley Essential Electrolytes and save 15% by visiting Paleovalley.com/jockers and using code JOCKERS at checkout.   If you're serious about reducing your toxic load, I highly recommend upgrading to the P600 ceramic cookware. It's 100% free from Teflon, PFAS, and plastic coatings, ensuring a non-toxic cooking experience. Right now, you can get it for 50% off, plus an extra 20% off with the code SAFE20 at checkout! Don't miss this limited-time offer—head to chefsfoundry.com/jockers to claim your discount today!     "Beta-glucans aren't just immune boosters—they're immune modulators, helping balance and strengthen your body's defenses against pathogens."      Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio     Resources: Get 15% off Paleovalley Electrolites: paleovalley.com/jockers – Use code JOCKERS Use code SAFE20 at chefsfoundry.com/jockers to claim your discount today!     Connect with Dr. Chris D'Adamo: Website - https://www.betterwayhealth.com/   Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

When Julia Stalder heard the words ductal carcinoma in situ, she was told she had the “best kind of breast cancer.” Which is like saying you got hit by the nicest bus. Julia's a lawyer turned mediator who now runs DCIS Understood, a new nonprofit born out of her own diagnosis. Instead of panicking and letting the system chew her up, she asked questions the industry would rather avoid. Why do women lose breasts for conditions that may never become invasive? Why is prostate cancer allowed patience while breast cancer gets the knife? We talked about doctors' fear of uncertainty, the epidemic of overtreatment, and what happens when you build a movement while still in the waiting room. Funny, fierce, unfiltered—this one sticks.RELATED LINKS• DCIS Understood• Stalder Mediation• Julia's story in CURE Today• PreludeDx DCISionRT feature• Julia on LinkedInFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Rachel Gatlin entered neuroscience with curiosity and optimism. Then came chaos. She started her PhD at the University of Utah in March 2020—right as the world shut down. Her lab barely existed. Her advisor was on leave. Her project focused on isolation stress in mice, and then every human on earth became her control group. Rachel fought through supply shortages, grant freezes, and the brutal postdoc job market that treats scientists like disposable parts. When her first offer vanished under a hiring freeze, she doubled down, rewrote her plan, and won her own NIH training grant. Her story is about survival in the most literal sense—how to keep your brain intact when the system built to train you keeps collapsing.RELATED LINKS• Dr. Rachel Gatlin on LinkedIn• Dr. Gatlin's Paper Preprint• Dr. Eric Nestler on Wikipedia• News Coverage: Class of 2025 – PhD Students Redefine PrioritiesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

EPISODE DESCRIPTIONBefore she was raising millions to preserve fertility for cancer patients, Tracy Weiss was filming reenactments in her apartment for the Maury Povich Show using her grandmother's china. Her origin story includes Jerry Springer, cervical cancer, and a full-body allergic reaction to bullshit. Now, she's Executive Director of The Chick Mission, where she weaponizes sarcasm, spreadsheets, and the rage of every woman who's ever been told “you're fine” while actively bleeding out in a one-stall office bathroom.We get into all of it. The diagnosis. The misdiagnosis. The second opinion that saved her life. Why fertility preservation is still a luxury item. Why half of oncologists still don't mention it. And what it takes to turn permission to be pissed into a platform that actually pays for women's futures.This episode is blunt, hilarious, and very Jewish. There's chopped liver, Carrie Bradshaw slander, and more than one “fuck you” to the status quo. You've been warned.RELATED LINKSThe Chick MissionTracy Weiss on LinkedInFertility Preservation Interview (Dr. Aimee Podcast)Tracy's Story in Authority MagazineNBC DFW FeatureStork'd Podcast EpisodeNuDetroit ProfileChick Mission 2024 Gala RecapFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As part of our deeper series on protein, perimenopause, and hormone health, this episode kicks off a multi-part exploration of soy—one of the most misunderstood yet most powerful foods in our plant-based toolkit.This podcast is listener-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.There's so much confusion around soy—does it act like estrogen? Does it affect hormones? And what about breast cancer? In this first episode of a multi-part series on soy, we walk through * what phytoestrogens really are (and aren't)* how isoflavones behave in the body* why soy foods are considered such a nutritional powerhouseWe explore: * what soy actually is* why it's so misunderstood in the West* the environmental realities behind global soy production* the unique benefits of tofu, tempeh, and edamame * estrogen-receptor–positive cancer and what the research really shows about it and its relationship to soyAll of this lays the groundwork for understanding soy's real role in our health—far beyond the myths and misinformation—and prepares us for Parts 2 and 3, where we'll explore soy's impact on menopause symptoms, hormone health, and how to incorporate these nourishing foods into your daily life with confidence and joy.*High-Protein Recipes Featuring Tofu, Tempeh, and EdamameIf you're enjoying this series and want practical, delicious ways to bring more soy foods into your life, don't miss my new recipe e-book, High-Protein Recipes Featuring Tofu, Tempeh, and Edamame. It features 12 savory, protein-rich recipes—spreads, soups, salads, sandwiches, and mains—all with 10-20 grams of protein per realistic serving. Each recipe includes a beautiful photo and full nutrition information to make meal planning easy and satisfying.Related Episodes* Protein-Packed Plant Foods (Ranked from Highest to Lowest)* Are You Eating Enough Protein? (Part One)* Are You Eating Enough Protein? (Part Two)* Omega-3s: Skip the Fish, Boost Your Brain, but Make Sure You're Getting Enough* Your Daily Supplement Guide: The Non-Negotiables and the Helpful Boosts* Building Strength and Muscle: Protein Intake, Protein Timing, and Lifting Heavy Sh*tSupport the PodcastTo keep Food for Thought Podcast ad-free and accessible to all, I rely on the support of paid subscribers. If you're already one—thank you. If you're not, please consider becoming one. None of the companies below sponsored this episode. They're simply brands I personally use, love, and trust—which is why I agreed to be an affiliate.If you make a purchase using the links below, I receive a small commission at no extra cost to you—and you'll receive exclusive discounts using the codes provided!* Complement SupplementsEverything you need, nothing you don't. Complement makes targeted supplements for plant-based eaters, including B12, D3, DHA, and more—all from clean, trusted sources.